3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hemangioma
4
Hemangioma, Capillary
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Anxiety Disorders
1
Interventions
Valganciclovir
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
Nivolumab
2
tocilizumab
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
emvododstat
1
efineptakin alfa
1
cabozantinib
1
Zidovudine
1
Sunitinib
1
Polymerase Chain Reaction
1
Nelfinavir
1
Maraviroc
1
Lenalidomide
1
Ipilimumab
1
Immunohistochemistry
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Etoposide
1
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
CTLA-4 Antigen
1
Antiretroviral Therapy, Highly Active
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Kaposi
×
Propranolol
×
Clear all
No trials found.